The Influence of Single-point Mutation D614G on the Binding Process Between Human Angiotensin-converting Enzyme 2 and the SARS-CoV-2 Spike Protein-an Atomistic Simulation Study

Overview

Journal RSC Adv

Publisher Royal Society of Chemistry

Specialty Chemistry

Date 2023 Mar 31

PMID 36998522

Authors

Chengcheng Shi

Yanqi Jiao

Chao Yang

Yao Sun

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2 has continuously evolved as changes in the genetic code occur during replication of the genome, with some of the mutations leading to higher transmission among human beings. The spike aspartic acid-614 to glycine (D614G) substitution in the spike represents a "more transmissible form of SARS-CoV-2" and occurs in all SARS-CoV-2 mutants. However, the underlying mechanism of the D614G substitution in virus infectivity has remained unclear. In this paper, we adopt molecular simulations to study the contact processes of the D614G mutant and wild-type (WT) spikes with hACE2. The interaction areas with hACE2 for the two spikes are completely different by visualizing the whole binding processes. The D614G mutant spike moves towards the hACE2 faster than the WT spike. We have also found that the receptor-binding domain (RBD) and N-terminal domain (NTD) of the D614G mutant extend more outwards than those of the WT spike. By analyzing the distances between the spikes and hACE2, the changes of number of hydrogen bonds and interaction energy, we suggest that the increased infectivity of the D614G mutant is not possibly related to the binding strength, but to the binding velocity and conformational change of the mutant spike. This work reveals the impact of D614G substitution on the infectivity of the SARS-CoV-2, and hopefully could provide a rational explanation of interaction mechanisms for all the SARS-CoV-2 mutants.

References

Shereen M, Khan S, Kazmi A, Bashir N, Siddique R . COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020; 24:91-98. PMC: 7113610. DOI: 10.1016/j.jare.2020.03.005. View

Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

Mannar D, Saville J, Zhu X, Srivastava S, Berezuk A, Zhou S . Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding. Cell Rep. 2021; 37(12):110156. PMC: 8642162. DOI: 10.1016/j.celrep.2021.110156. View

Xu C, Wang Y, Liu C, Zhang C, Han W, Hong X . Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Sci Adv. 2020; 7(1). PMC: 7775788. DOI: 10.1126/sciadv.abe5575. View

Faria N, Mellan T, Whittaker C, Claro I, Candido D, Mishra S . Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021; 372(6544):815-821. PMC: 8139423. DOI: 10.1126/science.abh2644. View

Tortorici M, Veesler D . Structural insights into coronavirus entry. Adv Virus Res. 2019; 105:93-116. PMC: 7112261. DOI: 10.1016/bs.aivir.2019.08.002. View

Zhou T, Tsybovsky Y, Gorman J, Rapp M, Cerutti G, Chuang G . Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains. Cell Host Microbe. 2020; 28(6):867-879.e5. PMC: 7670890. DOI: 10.1016/j.chom.2020.11.004. View

Liu Z, Moreira R, Dujmovic A, Liu H, Yang B, Poma A . Mapping Mechanostable Pulling Geometries of a Therapeutic Anticalin/CTLA-4 Protein Complex. Nano Lett. 2021; 22(1):179-187. PMC: 8759085. DOI: 10.1021/acs.nanolett.1c03584. View

Gomari M, Rostami N, Omidi-Ardali H, Arab S . Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study. J Biomol Struct Dyn. 2021; 40(12):5634-5642. PMC: 7832383. DOI: 10.1080/07391102.2021.1872418. View

10.

Campbell F, Archer B, Laurenson-Schafer H, Jinnai Y, Konings F, Batra N . Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021; 26(24). PMC: 8212592. DOI: 10.2807/1560-7917.ES.2021.26.24.2100509. View

11.

Shoemark D, Colenso C, Toelzer C, Gupta K, Sessions R, Davidson A . Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*. Angew Chem Int Ed Engl. 2021; 60(13):7098-7110. PMC: 8013358. DOI: 10.1002/anie.202015639. View

12.

Sahihi M, Faraudo J . Molecular Dynamics Simulations of Adsorption of SARS-CoV-2 Spike Protein on Polystyrene Surface. J Chem Inf Model. 2022; 62(16):3814-3824. PMC: 9364975. DOI: 10.1021/acs.jcim.2c00562. View

13.

Lorenzo-Redondo R, Nam H, Roberts S, Simons L, Jennings L, Qi C . A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways. EBioMedicine. 2020; 62:103112. PMC: 7655495. DOI: 10.1016/j.ebiom.2020.103112. View

14.

Kwarteng A, Asiedu E, Sylverken A, Larbi A, Sakyi S, Opoku Asiedu S . Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach. Infect Genet Evol. 2021; 91:104815. PMC: 7987576. DOI: 10.1016/j.meegid.2021.104815. View

15.

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

16.

Yadav R, Chaudhary J, Jain N, Kumar Chaudhary P, Khanra S, Dhamija P . Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19. Cells. 2021; 10(4). PMC: 8067447. DOI: 10.3390/cells10040821. View

17.

Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J . Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021; 592(7854):438-443. DOI: 10.1038/s41586-021-03402-9. View

18.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

19.

Kumar S, Thambiraja T, Karuppanan K, Subramaniam G . Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J Med Virol. 2021; 94(4):1641-1649. DOI: 10.1002/jmv.27526. View

20.

Koehler M, Ray A, Moreira R, Juniku B, Poma A, Alsteens D . Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants. Nat Commun. 2021; 12(1):6977. PMC: 8633007. DOI: 10.1038/s41467-021-27325-1. View